• Alpha Cognition swung to a third-quarter 2026 net loss of $7.62 million from a year-earlier profit.
• Net product revenue more than tripled year-over-year to $7.8 million, driven by increased sales volume.
• Bottles dispensed climbed 31% quarter-over-quarter to 10,896, while cumulative prescribers reached 2,410, exceeding the original full-year goal.
• Management reiterated 2026 R&D and SG&A expense guidance of $50 million–$54 million and maintained its goal of operating profitability in 2027.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alpha Cognition Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202611111605BIZWIRE_USPR_____20261111_BW978366) on November 11, 2026, and is solely responsible for the information contained therein.